The Need for Pediatric Drug Development

Robert M. Ward, Daniel K. Benjamin, Jonathan M. Davis, Richard L. Gorman, Ralph Kauffman, Gregory L. Kearns, Mary Dianne Murphy, Catherine M.T. Sherwin

Research output: Contribution to journalArticlepeer-review

Abstract

Therapeutic tragedies in pediatric patients contributed to formulation of the legal requirement that new medications had to be carefully studied before they could be approved for interstate sale. 1 Despite this, the majority of pediatric patients who require treatment are prescribed medications that are either not approved for pediatric use or contain incomplete directions for pediatric use in the approved product label

Original languageEnglish
Pages (from-to)13-21
Number of pages9
JournalJournal of Pediatrics
Volume192
DOIs
StatePublished - Jan 1 2018

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health

Keywords

  • BPCA
  • Institute for Advanced Clinical Trials for Children
  • International Neonatal Consortium
  • pediatric clinical trials
  • pediatric pharmacology
  • PREA

Disciplines

  • Medical Specialties
  • Medicine and Health Sciences
  • Pediatrics

Cite this